Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Marrow stromal stem cells
Paolo Bianco, Pamela Gehron Robey
Paolo Bianco, Pamela Gehron Robey
Published June 15, 2000
Citation Information: J Clin Invest. 2000;105(12):1663-1668. https://doi.org/10.1172/JCI10413.
View: Text | PDF
Perspective Article has an altmetric score of 9

Marrow stromal stem cells

  • Text
  • PDF
Abstract

Authors

Paolo Bianco, Pamela Gehron Robey

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
During development, precursor cells become committed to skeletogenesis u...
During development, precursor cells become committed to skeletogenesis upon induction of the critical osteogenic transcription factor, cbfa1. The initial phenotype expressed by these cells is that of fully mature osteoblasts. Subsequently, when a threshold amount of bone has been formed, these cells form the primitive bone marrow stroma that serves as the bed upon which hematopoiesis occurs. At some point during the postnatal period, when hematopoiesis is sufficient, these same cells change phenotype yet again to become marrow adipocytes. Cells of these three phenotypes (osteoblastic, myelosupportive, and adipocytic) form a continuous network throughout the bone–bone marrow organ and maintain expression of cbfa1. These differentiated cells are able to shift from one phenotype to another, depending on the metabolic status of the organism.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 8 patents
Referenced in 1 Wikipedia pages
Referenced in 1 clinical guideline sources
327 readers on Mendeley
See more details